# FDA Inspection 1010922 - Supernus Pharmaceuticals, Inc. - February 03, 2017

Source: https://www.keypedia.com/records/fda_inspections/supernus-pharmaceuticals-inc/c2d27c0d-ba92-4fea-b2c1-e2ad08305875
Source feed: FDA_Inspections

> FDA Inspection 1010922 for Supernus Pharmaceuticals, Inc. on February 03, 2017. Classification: Voluntary Action Indicated (VAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1010922
- Company Name: Supernus Pharmaceuticals, Inc.
- Inspection Date: 2017-02-03
- Classification: Voluntary Action Indicated (VAI)
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1280332 - 2025-07-31](https://www.keypedia.com/records/fda_inspections/supernus-pharmaceuticals-inc/77fd890a-f056-4747-a91a-9d2ffc1640d0)
- [FDA Inspection 1280332 - 2025-07-31](https://www.keypedia.com/records/fda_inspections/supernus-pharmaceuticals-inc/943ef880-afe6-4aef-b90a-6e4bb33021ec)
- [FDA Inspection 1109126 - 2019-10-10](https://www.keypedia.com/records/fda_inspections/supernus-pharmaceuticals-inc/733f0fc4-3ff3-48e3-b490-9202a9f70ec0)
- [FDA Inspection 1098819 - 2019-07-10](https://www.keypedia.com/records/fda_inspections/supernus-pharmaceuticals-inc/c71e8e72-2ed6-46af-868f-e722c7825d3a)
- [FDA Inspection 915034 - 2015-02-23](https://www.keypedia.com/records/fda_inspections/supernus-pharmaceuticals-inc/16af25c0-b18e-4c53-83fa-858febccf7f9)

Company: https://www.keypedia.com/companies/supernus-pharmaceuticals-inc/eff1a996-667f-4888-9fd8-50ca50265d74

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c